Suraksha Diagnostic IPO will be open on November 29, 2024. Today, we will share with you 10 important things about the company’s issues as follows:
1. Suraksha Diagnostic IPO Open and closing date?
Suraksha Diagnostic IPO’s open date is November 29, 2024 and the closing date is December 3, 2024.
2. What is the size of the Suraksha Diagnostic IPO?
The company Suraksha Diagnostic decided to raise around ₹846.25 crores via IPO and offer for sale up to 1,91,89,330 equity shares with face value of ₹2 each.
3. What are the subscription details of the Suraksha Diagnostic IPO?
For the Suraksha Diagnostic IPO, the price band of ₹420–441 per share. 34 shares is the minimum lot size required for a single application. Retail investors must make an investment of at least ₹14,994. The smallest lot size for small non-institutional investors is 14 lots (476 shares), or ₹209,916; the largest lot size for large non-institutional investors is 67 lots (2,278 shares), or ₹1,004,598.
4. What is the Suraksha Diagnostic IPO listing Date?
Suraksha Diagnostic is a mainboard IPO whose shares will be listed on 6th December 2024 on the BSE (Bombay Stock Exchange) and NSE (National Stock Exchange).
5. What are the objects of the Suraksha Diagnostic IPO Issue?
This issue is an Offer for sale and the object behind the IPO is to sell the shares. Suraksha Diagnostic will not get any profit from this issue.
6. About Suraksha Diagnostic
Suraksha Diagnostic was incorporated on 15 March 2005 and offers services like Medical testing, diagnostic solutions, and medical consultation. It is headquartered in East India and caters end-to-end solutions of pathology and radiology testing to its consumers through its functional network. It has a good portfolio of over 2,300 tests including 788 pathology tests like basic biochemistry and hematology. 647 tests including advanced biochemistry, histopathology, and molecular pathology. In FY 2022 and 2024, the compounded annual growth rate(CAGR) of 20.87% in revenue and net income for FY 2024 was 23.13 crore. Due to its expertise, it has 1,522 permanent staff in the company.
7. Suraksha Diagnostic Financials
The company reported revenue of ₹218.71 crores in 2024 against ₹190.13 crore in 2023. The company reported Profit of ₹23.13 crores in 2024 against Profit of ₹6.07 crores in 2023.
8. Suraksha Diagnostic IPO Promoters
The promoters of the company are Dr. Somnath Chatterjee, Ms. Ritu Mittal, and Mr. Satish Kumar Verma.
9. Suraksha Diagnostic IPO Risk factors
The main risk of Suraksha Diagnostic IPO is that over the past 3 years Company has had a low return on equity of 12.9%.
10. Who are the Suraksha Diagnostic IPO lead manager and registrar?
Nuvama Wealth and Investment Limited are the lead managers of Suraksha Diagnostic while KFin Technologies Limited is the registrar of the company.
